Importer of Controlled Substances Application: Mylan Technologies, Inc., 7859 [2017-01305]
Download as PDF
<![CDATA[
7859
Federal Register / Vol. 82, No. 13 / Monday, January 23, 2017 / Notices
written submissions, except for
confidential business information, will
be made available for inspection by
interested parties.
The Commission may include some or
all of the confidential business
information submitted in the course of
this investigation in the report it sends
to the USTR. Additionally, all
information, including confidential
business information, submitted in this
investigation may be disclosed to and
used: (i) By the Commission, its
employees and Offices, and contract
personnel (a) for developing or
maintaining the records of this or a
related proceeding, or (b) in internal
investigations, audits, reviews, and
evaluations relating to the programs,
personnel, and operations of the
Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government
employees and contract personnel (a)
for cybersecurity purposes or (b) in
monitoring user activity on U.S.
government classified networks. The
Commission will not otherwise disclose
any confidential business information in
a manner that would reveal the
operations of the firm supplying the
information.
Summaries of Written Submissions:
The Commission intends to publish
summaries of the positions of interested
persons. Persons wishing to have a
summary of their position included in
the report should include a summary
with their written submission. The
summary may not exceed 500 words,
should be in MSWord format or a format
that can be easily converted to MSWord,
and should not include any confidential
business information. The summary will
be published as provided if it meets
these requirements and is germane to
the subject matter of the investigation.
The Commission will identify the name
of the organization furnishing the
summary and will include a link to the
Commission’s Electronic Document
Information System (EDIS) where the
full written submission can be found.
mstockstill on DSK3G9T082PROD with NOTICES
By order of the Commission.
Issued: January 17, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–01401 Filed 1–19–17; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
19:02 Jan 19, 2017
Jkt 241001
DEPARTMENT OF JUSTICE
Controlled
substance
Drug
code
Schedule
Drug Enforcement Administration
Methylphenidate .......
Fentanyl ....................
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Mylan Technologies, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before February 22, 2017. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
February 22, 2017.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
31, 2016, Mylan Technologies, Inc., 110
Lake Street, Saint Albans, Vermont
05478 applied to be registered as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
1724
9801
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
Dated: October 22, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–01305 Filed 1–19–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Resource
Conservation and Recovery Act
On January 12, 2017, the Department
of Justice and the State of Louisiana on
behalf of the Louisiana Department of
Environmental Quality (‘‘LDEQ’’) filed a
Complaint and lodged a proposed
Consent Decree with the United States
District Court for the Middle District of
Louisiana in the matter of United States
of America and Louisiana Department
of Environmental Quality vs. Innophos,
Inc., Civil Action No. 17–26–SDD–RLB
(M.D. La.).
In the Complaint filed in this action,
the United States and LDEQ sought
injunctive relief and civil penalties
against Innophos, Inc. (‘‘Innophos’’) for
violations of the Resource Conservation
and Recovery Act (‘‘RCRA’’), 42 U.S.C.
6901–6992k, at Innophos’s purified
phosphoric acid manufacturing facility
near Geismar, Louisiana. The Complaint
alleged that Innophos routinely
generated two hazardous wastes,
Raffinate and RP Pondwater, and sent
them to an adjacent facility for disposal;
the receiving facility was not authorized
to dispose of hazardous waste. LDEQ is
a co-plaintiff and has brought its own
claims under state law.
The proposed Consent Decree
memorializes that Innophos has already
corrected the violations related to RP
Pondwater. Innophos also agrees in the
Consent Decree to handle Raffinate
appropriately, either by disposing of it
in a permitted hazardous waste
Underground Injection Control well
system, by treating it on-site, or by
shipping it to a permitted hazardous
waste treatment, storage, and disposal
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 82, Number 13 (Monday, January 23, 2017)]
[Notices]
[Page 7859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01305]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Mylan
Technologies, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before February 22, 2017. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before February 22, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
October 31, 2016, Mylan Technologies, Inc., 110 Lake Street, Saint
Albans, Vermont 05478 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methylphenidate....................... 1724 II
Fentanyl.............................. 9801 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form (FDF) from foreign sources for analytical testing
and clinical trials in which the foreign FDF will be compared to the
company's own domestically-manufactured FDF. This analysis is required
to allow the company to export domestically-manufactured FDF to foreign
markets.
Dated: October 22, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-01305 Filed 1-19-17; 8:45 am]
BILLING CODE 4410-09-P
